Comparison |
| Alternate Manufacturer Number |
3513678 | 2017226 | 1904341 | 3906187 | |
| Container Type |
Prefilled Syringe | Infusion Bottle | Flexible Bag | Single-Dose Vial | Single-Dose Vial |
| Country of Origin |
Unknown | India | Unknown | Unknown | Singapore |
| Generic Drug Code |
26368 | 25026 | 34228 | 19476 | 29261 |
| Generic Drug Name |
Ibandronate Sodium | Zoledronic Acid / Mannitol-Water | Zoledronic Acid / Mannitol-Water | Zoledronic Acid | Denosumab, Preservative Free |
| NDC Number |
60505609700 | 55111068852 | 25021083082 | 16714081501 | 55513073001 |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 180 days |
| Storage Requirements |
| | | | Requires Refrigeration |
| Strength |
1 mg / mL | 5 mg / 100 mL | 5 mg / 100 mL | 4 mg / 5 mL Concentrate | 120 mg |
| Type |
Intravenous | Intravenous | Intravenous | Intravenous | Subcutaneous |
| UNSPSC Code |
51182423 | 51182415 | 51182415 | 51182415 | 51182428 |
| Volume |
3 mL | 100 mL | 100 mL | 5 mL | 1.7 mL |
| Application |
Bone Resorption Inhibitor | Bone Resorption Inhibitor | Bone Resorption Inhibitor | Bone Resorption Inhibitor | Bone Resorption Inhibitor |
| Dosage Form |
Injection | Injection | Injection | Injection | Injection |
| Features and Benefits |
|
- Ready-to-use formulation
- Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy, multiple myeloma and bone metastases from solid tumors
- The zoledronic acid injection infusion time must not be less than 15 minutes given over a constant infusion rate
- Zoledronic acid injection must not be mixed with calcium or other divalent cation-containing infusion solutions, such as Lactated Ringer’s solution, and should be administered as a single intravenous solution in a line separate from all other drugs
- Infusion bottle with built-in plastic hanger
- One bottle with 100 mL solution contains 5.330 mg of zoledronic acid monohydrate, equivalent to 5 mg zoledronic acid on an anhydrous basis
- Inactive Ingredients: 4950 mg of mannitol, USP; and 30 mg of sodium citrate, USP
|
|
|
|
